The relationship between cancer patient's fear of recurrence and chemotherapy : a systematic review and meta-analysis
MetadataShow full item record
Altmetrics Handle Statistics
Altmetrics DOI Statistics
Objective: The study aim was to provide an overview of the current evidence available on the link between chemotherapy (CTX) and fear of cancer recurrence (FoR). Methods: PubMED, Medline, Embase, PsycINFO and Web of Science databases were searched to identify relevant studies. Two authors independently selected and assessed the studies regarding eligibility criteria. Meta-analysis of suitable studies was conducted, and quality rated. Results: Forty eligible studies were included in the systematic review and twenty-nine of them were included in further meta-analysis. Meta-analysis of the available data confirmed a weak relationship between CTX and FoR (29 studies, 30,176 patients, overall r = 0.093, 95%, CI: 0.062–0.123, P < 0.001). Conclusions: The meta-analysis demonstrates a weak but significant relationship between cancer patient's FoR and the receipt of chemotherapy. However, these results should be interpreted with caution. Further investigation is warranted to explore possible mechanisms of FoR increase in patients who receive chemotherapy. Longitudinal studies assessing the trajectory of FoR during chemotherapy are also warranted.
Yang , Y , Wen , Y , Bedi , C & Humphris , G 2017 , ' The relationship between cancer patient's fear of recurrence and chemotherapy : a systematic review and meta-analysis ' , Journal of Psychosomatic Research , vol. 98 , pp. 55-63 . https://doi.org/10.1016/j.jpsychores.2017.05.002
Journal of Psychosomatic Research
© 2017 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/BY-NC-ND/4.0/).
DescriptionThis review was funded by Breast Cancer Now (grant number 6873).
Items in the St Andrews Research Repository are protected by copyright, with all rights reserved, unless otherwise indicated.